Present Scenario and Future Prospectives Of Herbal Nanomedicine Use in Antifungal Therapy

Herbal nanomedicines, which combine plantderived bioactive compounds with nanotechnology, offer a promising approach in antifungal treatment. Nanocarrier systems, such as liposomes, niosomes, micelles, and solid nanoparticles, have been widely used to improve solubility, stability, bioavailability, and targeted delivery of herbal antifungal agents. The need for safer and more effective therapies has been driven by the rising incidence of fungal infections and antifungal resistance. Liposomes and niosomes provide biocompatible vesicular systems capable of encapsulating both hydrophilic and lipophilic phytoconstituents, improving controlled release and minimizing toxicity. Micelles, formed by amphiphilic surfactants, effectively solubilize poorly soluble herbal compounds and promote better membrane penetration. Solid nanoparticles further enhance antifungal efficacy by improving stability, circulation time, and site-specific drug delivery. Preclinical studies have demonstrated improved antifungal activity, reduced toxicity, and synergistic effects with conventional antifungals. However, clinical translation remains limited due to challenges such as poor standardization of herbal extracts, lack of formulation reproducibility, difficulties in large-scale manufacturing, and regulatory uncertainties. Future directions focus on developing novel biocompatible nanocarriers, optimizing formulation techniques, and conducting systematic clinical evaluations to ensure safety and efficacy. The integration of green nanotechnology, targeted delivery, and multi-herbal formulations holds great potential to revolutionize antifungal therapy. Overall, herbal nanomedicines represent a sustainable, effective, and innovative strategy to combat fungal infections and address the growing problem of drug resistance.